SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Seattle Biotech
An SI Board Since February 2000
Posts SubjectMarks Bans
70 9 0
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
45Call for Abstracts - Northwest Gene Expression Conference htscreening.netMike McFarland-5/11/2003
44Fourth annual Northwest Gene Expression Conference (formerly known as the NorthwMike McFarland-4/25/2003
43A short interview with Steve Gillis in the SeattleTimes seattletimes.nwsource.coMike McFarland-4/7/2003
42ZymoGenetics breaks ground on $26 million, 45,000-square-foot expansion of its rMike McFarland-4/5/2003
41NIH Extends Study To Evaluate Kaleidos Pharma's Lead Drug Candidate For The keokalani'nui-1/28/2003
40Kaleidos Pharma, Inc. Announces Collaboration With the NIH to Investigate TGF-alkeokalani'nui-9/26/2002
39NWBT - hadn't noticed that; thanks. <i>July 29 /PRNewswire-FirstCallnigel bates-9/3/2002
38Venture Capital: Seattle biotech shakeout under way, some fear Friday, August 3keokalani'nui-9/3/2002
37ISB/ABI Message 17922615 <i>improved LC MALDI workflows for high throughpMike McFarland-8/27/2002
36(Hartwell mentioned, systems biology, "phenomenology") 2. ON THE COUPMike McFarland-7/19/2002
35Zymo has something with an interesting name C1QTNF1, a site specific platelet ackeokalani'nui-11/9/2001
34Leland H. Hartwell - Hutch - Nobel Prize in Medicine Awarded Leland H. HartwellCheryl Galt-10/8/2001
33<i>Zymogenetics/Celltech Phase II Results for platelet-derived growth factkeokalani'nui-10/7/2001
32BERLIN, GERMANY AND SEATTLE, WA--(INTERNET WIRE)--Sep 09, 2001-- Epigenomics, a nigel bates-9/10/2001
31ZymoGenetics and Serono to Collaborate on a Novel Therapeutic Approach For Autoikeokalani'nui-9/4/2001
30ZymoGenetics Names George B. Rathmann as Chairman of the Board SEATTLE, July 19 keokalani'nui-7/19/2001
29Nothing they're letting us know about - zymogenetics.com nignigel bates-7/17/2001
28Wonder what's going on at Zymogenetics. Anyone heard news of its debut?keokalani'nui-7/16/2001
27Corus Pharma Secures $18.5 Million in Private Placement Investment Community Shokeokalani'nui-6/6/2001
26They do things differently in Germany. Imagine reading "...the <b>US&nigel bates-5/16/2001
25Misc... TAPs--from RedHerring, mentions the SGEN IPO redherring.com --by the wMike McFarland-3/25/2001
24Mike, in this last Fri issue you probably noticed the Nowinski CNS start-up. Ackeokalani'nui-3/24/2001
23Several short articles in the March 16th PSBJ seattle.bcentral.com Eden seattlMike McFarland-3/24/2001
22Has anyone looked at Epoch Biosciences (Pharmaceuticals) EBIO? Company is positJR-8/12/2000
21RSTA completed an initial public offering of 7,200,000 shares of its common stoMike McFarland-8/9/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News